Results from univariate sensitivity analyses, showing the ten parameters with the greatest influence on the cost-effectiveness of Xpert compared to status quo, South Africa.

<p>Sensitivity analyses on the incremental cost per DALY averted (2011 US dollars) over a 10-y analytic horizon, assuming a US$30 Xpert per-test cost. In each one-way analysis, one parameter was varied ±1 standard deviation from its posterior mean, with all other variables fixed at their posterior means.